InvestorsHub Logo
Followers 18
Posts 1416
Boards Moderated 0
Alias Born 12/03/2013

Re: None

Monday, 04/17/2017 7:50:13 AM

Monday, April 17, 2017 7:50:13 AM

Post# of 48316
Just a small word of caution as we await the start of the registration study. ONCS has enough cash until sometime in the 1st Qtr 2018...and that's taking into consideration (per the company) that there will be a drug partnership deal. Regardless of what pop we may get with the start of the trial, based upon history, I believe there's a good chance of dilution in the 3rd qtr this year...JMHO. I am also hopeful that they will have more good interim data from the current combo trial to be able to present at ASCO.